story of the week
Association Between sNfL Levels and 12-Month Outcomes in Patients With MS
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of Neurology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
In multiple sclerosis patients a single serum neurofilament light chain (sNFL) dosage is strongly associated with 12 months outcome: data from a real-life clinical setting
J Neurol 2024 Sep 23;[EPub Ahead of Print], S Malucchi, CI Bava, P Valentino, S Martire, M Lo Re, A Bertolotto, A Di SapioFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.